Home/Filings/4/0001209191-15-086990
4//SEC Filing

HERON THERAPEUTICS, INC. /DE/ 4

Accession 0001209191-15-086990

$HRTXCIK 0000818033operating

Filed

Dec 23, 7:00 PM ET

Accepted

Dec 24, 12:29 PM ET

Size

8.8 KB

Accession

0001209191-15-086990

Insider Transaction Report

Form 4
Period: 2015-12-22
Drazba Brian G.
Chief Financial Officer
Transactions
  • Other

    Common Stock

    2015-10-30$9.36/sh+714$6,6822,683 total
  • Award

    Stock Option (Right to Buy)

    2015-12-22+50,00050,000 total
    Exercise: $29.41Exp: 2025-12-22Common Stock (50,000 underlying)
  • Other

    Common Stock

    2015-04-30$7.60/sh+1,151$8,7461,969 total
Footnotes (2)
  • [F1]Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan.
  • [F2]The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant.

Issuer

HERON THERAPEUTICS, INC. /DE/

CIK 0000818033

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000818033

Filing Metadata

Form type
4
Filed
Dec 23, 7:00 PM ET
Accepted
Dec 24, 12:29 PM ET
Size
8.8 KB